 |
Evaluating Science
Science has become the foundation of biotech business. With this, investment decisions into early stage biotech companies critically depend on expert knowledge of the underlying science.
Peer review, the process that drives scientific progress, draws on the knowledge of the entire scientific community by choosing from hundreds of ad hoc reviewers, each a specialist in a particular area of science. By contrast, investment companies evaluate the scientific concepts and technologies that form the basis of future biotech companies by rather inexperienced scientists or a small group of advisors.
| |
|
|
Making Decisions on a Solid Foundation
evalueSCIENCE Ltd. is the first consulting firm to offer Science Due Diligence and Expert Peer Review services to investment companies, academic institutes and government bodies.
The company draws on a large international pool of evalueSCIENCE Experts, each a specialist in a particular area of the life sciences, with significant experience in biotech or pharma based research. In order to perform a Science Due Diligence, the evalueSCIENCE Experts access their own personal peer network.
evalueSCIENCE typically conducts a peer review process for clients that do not have the expertise, resources or the networks necessary to perform their own in-depth assessment. With its services evalueSCIENCE complements the well established legal and financial due diligence.
In addition to its large expert base, evalueSCIENCE offers a flexible and standardized scientific due diligence process that is based on its proprietary Science Due Diligence (SDDS) platform.
| |
|
